P emphigus V ulgaris: U pdate on E tiopathogenesis, O ral M anifestations, and M anagement
Critical Reviews in Oral Biology & Medicine · 2002-09 · 13 (5) · 397-408
DOI: 10.1177/154411130201300504 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Critical Reviews in Oral Biology & Medicine, online erschienen am 01.09.2002. Verfasst von Crispian Scully und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Medicine, Eastman Dental Institute for Oral Health Care Sciences, University College London, University of London, 256 Gray's Inn …. Die Arbeit wurde bisher 110-mal zitiert (Crossref) und nennt 179 Literaturangaben.
Abstract (Originalsprache)
Pemphigus is a group of potentially life-threatening diseases characterized by cutaneous and mucosal blistering. There is a fairly strong genetic background to pemphigus with linkage to HLA class II alleles. Certain ethnic groups, such as Ashkenazi Jews and those of Mediterranean origin, are especially liable to pemphigus. Pemphigus vulgaris (PV), the most common and important variant, is an autoimmune blistering disease characterized by circulating pathogenic IgG antibodies against desmoglein 3 (Dsg3), about half the patients also having Dsg1 autoantibodies. Oral lesions are initially vesiculobullous but readily rupture, new bullae developing as the older ones rupture and ulcerate. Biopsy of perilesional tissue, with histological and immunostaining examinations, is essential to the diagnosis. Serum autoantibodies to either Dsg1 or Dsg3 are best detected by both normal human skin and monkey esophagus or by enzyme-linked immunosorbent assay (ELISA). Before the introduction of corticosteroids, pemphigus vulgaris was typically fatal mainly from dehydration or secondary systemic infections. Current treatment is largely based on systemic immunosuppression using systemic corticosteroids, with azathioprine, dapsone, methotrexate, cyclophosphamide, and gold as adjuvants or alternatives, but mycophenolate mofetil and intravenous immunoglobulins also appear promising.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Oral Medicine, Eastman Dental Institute for Oral Health Care Sciences, University College London, University of London, 256 Gray's Inn Road, London WC1X 8LD, UK. scully.c@eastman.ucl.ac.uk
Zitieren
APA
Scully, C., & Challacombe, S. J. (2002). P emphigus V ulgaris: U pdate on E tiopathogenesis, O ral M anifestations, and M anagement. Critical Reviews in Oral Biology & Medicine, 13(5), 397-408. https://doi.org/10.1177/154411130201300504
Vancouver
Scully C, Challacombe SJ. P emphigus V ulgaris: U pdate on E tiopathogenesis, O ral M anifestations, and M anagement. Critical Reviews in Oral Biology & Medicine. 2002;13(5):397-408. doi:10.1177/154411130201300504
BibTeX
@article{Scully2002,
author = {Scully, Crispian and Challacombe, Stephen J},
title = {P emphigus V ulgaris: U pdate on E tiopathogenesis, O ral M anifestations, and M anagement},
journal = {Critical Reviews in Oral Biology & Medicine},
year = {2002},
volume = {13},
number = {5},
pages = {397--408},
doi = {10.1177/154411130201300504}
}
EUVIMED